mRNA, Protein Vaccine Compositions for Influenza

Sat, 11 Apr 2026 15:29:17 +0000
Intellectual Property

The USPTO published patent application US20260097112A1 by inventors Jacob Glanville et al. covering vaccine compositions comprising combinations of influenza antigens. The application discloses mRNA/LNP, recombinant protein, virus-like particle (VLP), and DNA vaccine formulations. Filing date was October 17, 2025.